Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » ENETS Conference 2023

ENETS Conference 2023

  • March 27, 2023

ENETs was held in Vienna at the Austria Centre from 22 – 24 March 2023. There were 850 attending the conference in person from all over the world and more were attending virtually.

Our CEO Meredith Cummins attended and stated it was a wonderful conference. There were fabulous opportunities to network and collaborate on projects such as patient education videos and nursing education, competencies, and INCA activities. Meredith presented to some of Ipsen’s Global team giving an overview of the PLANET Registry and the PLANET App, highlighting the benefits of PROMs during consultations and keeping a living diary.

NECA was co-authors of 2 posters – “Treatment Preferences for SSAs in NETs among patients, clinicians and nurses in Australia” and “Development of a novel NET nutrition screening tool to identify patients requiring nutrition-related intervention and support”.

The program was comprehensive and discussed diagnostic challenges and dilemmas in NETs which looked at pathology, biomarkers, imaging (including FDG PETs), and the matter of whether we should re-biopsy during the course of the disease.

Another session looked at NET emergencies  – hormonal crises and management, mesenteric fibrosis, bone metastases, and the role of bisphosphonates and nutrition support – sarcopenia and malnutrition. Then becoming familiar with ENETs new guidance papers such as localised appendix NET 1-2cm and functioning pNET.

INCA / ENETs had a symposium that focused on working together to improve patient outcomes which included a patient story, “Think NENs educational program for GPs” and the aspiration of an Optimal Care Pathway. From our Australian perspective, it was very heartening to know that the education program and the Optimal Care Pathway have been achieved in Australia.

The afternoon session on Thursday presented on Mixed Neuroendocrine  – Non-Neuroendocrine neoplasms – concepts, challenges, and treatment – the conclusion was that this, worldwide, is a difficult area. Then there were nutritional aspects of NETs – advanced GEPNETs and the obesity paradox of GEPNETs.

The final day of the conference covered new developments in systemic therapy of NETs including targeted and potential agents and also a nurses and dietitians symposium when Erin Laing was an invited speaker to ENETs and presented the Nutrition Screening tool, further discussion of sarcopenia in patients with NETs and an interesting case study with a panel discussion about a patient with complex nutritional needs.

ENETs is such a valuable conference that brings the world’s Multidisciplinary NET Healthcare Professionals together – to explore best practice, learn from each other and create opportunities to improve NET patient outcomes.

Share this post

Recent posts

VHL Awareness Month 2025

May 6, 2025

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

May 5, 2025

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

April 29, 2025

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

April 5, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousMichael Doyle Live Wake Fundraiser
NextMichael Usher joins NECA as an AmbassadorNext

Related Posts

VHL Awareness Month 2025

May is internationally recognised as Von Hippel-Lindau (VHL) Awareness Month—a time to highlight this rare genetic, and in some case not genetic, condition and the

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

Jo O’Halloran was in her early fifties when the symptoms she and her friends had heard so much about started to appear. ‘I was always

Neuroendocrine Cancer in Budget 2025–26

The 2025–26 Federal Budget, delivered by the Treasurer Hon Jim Chalmers on 25th March, included a welcome investment of $256.2 million over four years from 2025–26 (and

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin